Wecasa

Healthcare & Medical • Francewww.wecasa.co.uk

Review data last updated August 16, 2026.

Request Custom AnalysisSign up free to see everything

Based on public reviews and response behavior.

Overall Score

50/100

−6.2 vs. last month4.33 ★ average rating · 706 reviews

Competitive Performance Rank

Among fully-analyzed Healthcare & Medical companies

#437of 615

Top 71% · Mid Pack

#1 (best)#615 (worst)

#435Peer

#436Peer

#437This company

#438Peer

#439Peer

Overall Customer Sentiment

Mid Pack

78% of reviews positive, 21% negative

78%

positive

Positive78%
Neutral2%
Negative21%

Sentiment Balance

Covering July 2026 — 63 reviews, not the company's full review history.

Positive sentiment

Neutral sentiment

Negative sentiment

—

positive

Positive—
Neutral—
Negative—

Takeaway: Positive sentiment accounts for 67% of reviews in this period, with 32% negative and 2% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 701 reviews across the months with enough data to chart reliably (min 3/month), most recent: July 2026.

Sentiment has been declining over the period shown.

Theme Distribution

Share of theme mentions

Product Quality

22.7%

Customer Support

19.7%

Loyalty

13.7%

Onboarding

11.7%

Pricing

8.8%

Most feedback concerns Product Quality.

The most common complaint theme is Pricing, making up 8.8% of all theme mentions.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

MEDIUM35/100

35/100

signal score

•Built from a negative-review share of 20.7% across this company's analyzed reviews.
•7 reviews contain phrases that signal intent to leave, such as cancelling or switching provider.
•The share of negative reviews has held steady over time, so the trend doesn't move the score.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

4.3avg rating

5★

76.6%

4★

7.4%

3★

2.0%

2★

0.8%

1★

13.2%

Based on 706 analyzed reviews. Sentiment is holding steady: 89.2% of reviews in the last three months were positive, compared with 89.5% in the three months before that.

Unlock full insights